key: cord-299143-vcfu79ij
authors: McCoy, John; Wambier, Carlos Gustavo; Herrera, Sabina; Vaño‐Galván, Sergio; Gioia, Francesca; Comeche, Belen; Ron, Raquel; Serrano‐Villar, Sergio; Iwasiow, Rafal M; Tayeb, Michael A; Cadegiani, Flávio Adsuara; Mesinkovska, Natasha Atanaskova; Shapiro, Jerry; Sinclair, Rodney; Goren, Andy
title: Androgen Receptor Genetic Variant Predicts COVID‐19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID‐19 Male Patients
date: 2020-09-25
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.16956
sha: 
doc_id: 299143
cord_uid: vcfu79ij

Men infected with SARS‐CoV‐2 are more likely to be admitted to the intensive care unit (ICU) compared to women.(1) Previously, we have reported that among hospitalized men with COVID‐19, 79% presented with androgenetic alopecia (AA) compared to 31‐53% that would be expected in a similar aged match population.(2) AA is known to be mediated by variations in the androgen receptor (AR) gene.(3) In addition, the only known promoter of the enzyme implicated in SARS‐CoV‐2 infectivity, TMPRSS2, is regulated by an androgen response element.(4) The polyglutamine repeat (CAG repeat) located in the AR gene is associated with androgen sensitivity and AA.(3) These observations led us to hypothesize that variations in the AR gene may predispose male COVID‐19 patients to increased disease severity.

This article is protected by copyright. All rights reserved To the Editor, Men infected with SARS-CoV-2 are more likely to be admitted to the intensive care unit (ICU) compared to women. 1 Previously, we have reported that among hospitalized men with COVID-19, 79% presented with androgenetic alopecia (AA) compared to 31-53% that would be expected in a similar aged match population. 2 AA is known to be mediated by variations in the androgen receptor (AR) gene. 3 In addition, the only known promoter of the enzyme implicated in SARS-CoV-2 infectivity, TMPRSS2, is regulated by an androgen response element. 4 The polyglutamine repeat (CAG repeat) located in the AR gene is associated with androgen sensitivity and AA. 3 These observations led us to hypothesize that variations in the AR gene may predispose male COVID-19 patients to increased disease severity.

We conducted a prospective longitudinal study of hospitalized COVID-19 males. The subjects were categorized into two cohorts: subjects with a CAG>=22 and subjects with a CAG<22. Subjects taking androgen modifying drugs, e.g., 5ARis, were excluded. DNA was collected using ORAcollect•Dx: (DNAGenotek, Ottawa, Canada). AR CAG repeat region was PCR-amplified and 300bp paired-end sequencing was performed using a MiSeq (Illumina, San Diego, California). Reads were mapped to reference AR sequences containing 1 to 50 CAG repeats, the reference with the greatest number of mapped reads was reported as the CAG repeat count. Subjects were followed for a period of 60 days from the date of hospitalization. Primary and secondary outcomes were the rate of ICU admissions and length of hospitalization, respectively. 77 COVID-19 positive men were recruited to the study; 12 were excluded due to their use of androgen modifying drugs, leaving 65 patients enrolled in the study. 31 (48%) subjects had a CAG<22, with average age of 67.9 (+/-12.3). The median duration of hospitalization among subjects with a CAG<22 was 25 days (95% CI: 9.000-41.6512), and 14 (45.2%) were admitted to the ICU. 34 (52%) subjects had a CAG>=22, their average age was 65.0 (+/-12.15). Among the 34 subjects with a CAG>=22, the median duration of hospitalization was 47.5 days (95% CI: 22.9533-49.0935), and 24 (70.6%) were admitted to the ICU.

The proportion of subjects admitted to the ICU with CAG<22 was significantly lower than the proportion of subjects with CAG>=22 (Fisher's exact test p= 0.046791. Subjects with a CAG>=22 had a higher risk for ICU admissions compared to subjects with a CAG<22: OR 2.9143(95% CI: 1.0487-

This article is protected by copyright. All rights reserved 8.0985) and Likelihood Ratio 1.705(95% CI: 0.985-2.951). Further, estimating 40% of hospitalized COVID-19 male patients are likely admitted to the ICU, 5 the Bayes' adjusted positive predictive value of the AR CAG score in predicting ICU admissions was 53.202% (95%CI: 39.646%-66.301%) and the negative predictive value was 71.938% (95%CI: 60.693%-80.974%).

Our data suggest that longer AR CAG score is associated with more severe COVID-19 disease.

In some androgen mediated disease, short CAG has been associate with worse prognosis, e.g., in prostate cancer. 6 However, in skeletal muscle, a long CAG repeat length produces higher androgen mediated activity. 7 We believe this discrepancy can be explained by the tissue dependent expression of co-factors important for activation of the androgen response element (ARE). 8 For example, protein arginine methyltransferase 6 has been shown to be highly expressed in lung and has been shown to be a specific co-activator of the androgen receptor. 9 The results of this study suggest that the AR CAG repeat length could potentially be used as a biomarker to identify male COVIID-19 patients at risk for ICU admissions. More importantly, identification of a biomarker associated with the androgen receptor is yet another piece of evidence supporting the important role of androgens in SARS-CoV-2 disease severity. We recognize the limitations of this small study; however, our findings, combined with previous reports implicating androgens in COVID-19 disease severity, [3] [4] [5] should encourage other groups to explore interventional studies of anti-androgens in COVID-19 patients. Currently, we are conducting a double-blinded interventional study with dutasteride (NCT04446429).

Sex hormones signal why virus hits men harder

Impact of sex and gender on COVID-19 outcomes in Europe

Androgen sensitivity gateway to COVID-19 disease severity

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients -the "Gabrin sign

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)

Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action

Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy

Accepted Article

This article is protected by copyright. All rights reserved